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Abstract
Objective—To examine how clinicians communicate with parents about influenza vaccination
and the effect of these communication behaviors on parental vaccine decision-making.
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Study Design—We performed a secondary analysis of data obtained from a cross-sectional
observational study in which health supervision visits between pediatric clinicians and Englishspeaking parents of young children were videotaped. Eligible visits occurred during the 2011–
2012 and 2013–2014 influenza seasons, included children ≥6 months, and contained an influenza
vaccine discussion. A coding scheme of 10 communication behaviors was developed and applied
to each visit. Associations between clinician communication behaviors and parental verbal vaccine
acceptance and parental visit experience were examined using bivariate analysis and generalized
linear mixed models.
Results—Fifty visits involving 17 clinicians from 8 practices were included in analysis. The
proportion of parents who accepted influenza vaccine was higher when clinicians initiated
influenza vaccine recommendations using presumptive rather than participatory formats (94% vs.
28%, p<0.001; adjusted odds ratio 48.2, 95% CI 3.5–670.5). Parental acceptance was also higher
if clinicians pursued (vs. did not pursue) original recommendations when parents voiced initial
resistance (80% vs. 13%, p<0.05) or made recommendations for influenza vaccine concurrent with
(vs. separate from) recommendations for other vaccines due at the visit (83% vs. 33%, p<0.01).
Parental visit experience did not differ significantly by clinician communication behaviors.
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Conclusion—Presumptive initiation of influenza vaccine recommendations, pursuit in the face
of resistance, and concurrent vaccine recommendations appear to increase parental acceptance of
influenza vaccine without negatively affecting visit experience.
Keywords
Communication; pediatricians; nurse practitioners; parents; infants; influenza vaccines;
vaccination; vaccination refusal

INTRODUCTION

Author Manuscript

Influenza causes significant morbidity and mortality among U.S. children.1–3 The influenzaassociated hospitalization rate among children <5 years of age was 57.2 per 100,000 in
2014, and there have been between 34 and 358 influenza-associated pediatric deaths each
year since 2004.3 Although it is recommended that all persons ≥6 months of age without
contraindications be vaccinated against influenza annually,2 only 59.3% of U.S. children
were vaccinated in the 2015–2016 season.4

Author Manuscript

Evidence suggests that clinician recommendation is associated with parental acceptance of
influenza vaccine for their child5,6 and that clinician recommendation may be sufficient for
parents to overcome influenza-related concerns.7 There are no data, however, describing
actual clinician communication with parents about influenza vaccine or the impact of
specific behaviors on influenza vaccine acceptance. We previously found that the clinician
initiation format for recommending other (non-influenza) childhood vaccines was associated
with parental acceptance of those vaccines and parental visit experience.8,9 The objectives of
this study, therefore, were to: (1) characterize influenza vaccine communication between
pediatric clinicians and parents of children aged 6–19 months in the primary care setting;
and (2) determine whether certain clinician recommendation practices are associated with
parental acceptance of influenza vaccine for their child and parental visit experience.

METHODS
Study Design
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We conducted a secondary analysis of videotaped health supervision visit data collected over
2 periods (period 1: September 2011–August 2012, n=113; period 2: April 2013–June 2014,
n=103) as part of a cross-sectional observational study aiming to characterize clinicianparent communication about childhood vaccines. A primary analysis of period 1 data was
published previously and focused on clinician-parent communication about routine (noninfluenza) childhood vaccines.8,9 This study was approved by the Seattle Children’s
Hospital Institutional Review Board.
Participants
We recruited 23 pediatricians and pediatric nurse practitioners from 16 primary care
pediatric practices in the Seattle area over the 2 study periods. Parents of children receiving
care from a participating clinician were approached in the practice waiting room. Eligible
parents were ≥18 years of age, English-speaking, and had a child aged 1–19 months being
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seen for a health supervision visit. Parents were screened for vaccine hesitancy using the
validated Parent Attitudes about Childhood Vaccines (PACV) survey,10–12 which was
embedded into a larger survey about common childhood topics. Vaccine hesitant parents
(VHPs), defined as those with a total PACV score of ≥50 (scale 0–100),11,12 were
oversampled in period 1 and the only participants enrolled in period 2. To minimize the
chance that participants altered their vaccine-specific behaviors to meet observer
expectation, the study was described as one that sought to better understand general
clinician-parent communication.
Data Collection

Author Manuscript

All study visits were videotaped. Parents completed a post-visit survey with 11 demographic
items and 15 items pertaining to their visit experience adapted from the validated Outpatient
Satisfaction Questionnaire13 and Satisfaction with Immunization Service Questionnaire14
(Appendix A). Videos were edited to contain only the vaccine discussion and subsequently
transcribed.
Analysis
Videotaped visits were included in the analysis if they occurred during the typical influenza
vaccination season (August–March), involved a child ≥6 months of age, and contained a
discussion about influenza vaccine for the child.
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Coding—One investigator (JDR) used conversation analysis with a subset of the data to
refine the coding scheme developed in the primary analysis,8,9,15 verifying previously
identified communication behaviors as relevant to the influenza vaccine discussion and
identifying any unique communication behaviors for influenza vaccine. These were
reviewed by another investigator (DJO). The final coding scheme contained 10 influenza
vaccine communication behaviors (Appendix B). The two investigators (JDR, DJO) then
conducted a 1.5-day, in-person training for 4 coders (AH, KL, MC, NE) on the final coding
scheme using 28% of the data. Intercoder reliability was tested on an additional 40% of the
data, with κ ranging from 0.71 to 1.0 (mean κ=0.83). All 4 coders coded the remaining data
independently. Discrepancies were resolved by independent review and subsequent
discussion by JDR and DJO. Coders were blinded to parental PACV scores.
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Variables—The primary dependent variables were parental verbal acceptance (or not) of
influenza vaccine for their child by the visit’s end, assessed at the time of coding, and
parental visit experience. For the latter, individual responses on the 15-item visit experience
measure were scored from 1 (“very poor”) to 7 (“outstanding”) and summed in an
unweighted fashion to calculate a total raw score (range: 15–105). A highly rated visit
experience was denoted by a score ≥90, whereas a lower rated visit experience was denoted
by a score <90.9 Five parents had missing visit experience responses. Adjusting the total
score by number of questions answered did not alter the findings; thus, the total raw score
was used for all analyses. Two alternative approaches to scoring the visit experience measure
were also used. First, a different dichotomization threshold was used, consistent with the
top-box scoring method used in Consumer Assessment of Healthcare Providers and System
measures16 and parent–patient experience research.17–19 Parents who rated all 15 items with
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the highest response category (7) were coded as having a highly rated visit experience, while
parents who rated any item <7 were coded as having a lower rated experience. Second, a
separate visit experience variable comprised of only the 5 vaccine-related visit experience
items was created with a total raw score range of 7–35 (see asterisked items, Appendix A).
A highly rated vaccine-related visit experience was defined in two ways: (1) total score ≥30
(i.e., 6 or 7 on all 5 items); and (2) total score ≥28 (the median total raw score). Neither
alternative approach changed the findings; thus, only data using the first approach are
presented.
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Secondary outcomes included parental acceptance (or not) immediately after clinician
initiation of the influenza vaccine recommendation and, if the parent voiced immediate
resistance to this recommendation, parental acceptance (or not) immediately after clinician
pursuit (if present). Verbal resistance was coded when a parent: (1) rejected the clinician
recommendation explicitly (e.g., “I don’t do the flu shot”); (2) demurred (e.g., “I don’t
know”); (3) proposed a contingency as an obstacle to acceptance (e.g., “He has a birthday
party tomorrow”); or (4) raised questions or concerns in response to the recommendation
(e.g., “Do they have to have it?”). Resistance types were dichotomized into explicit (code 1
above) vs. non-explicit (codes 2–4) rejections. The primary independent variable was the
communication format used by clinicians to initiate the influenza vaccine recommendation.
As in our previous analyses, 8,9 this was dichotomized into ‘presumptive’ and
‘participatory.’ Presumptive formats are linguistically designed to presuppose acceptance,
biasing answers toward acceptance. Clinician declarations that influenza vaccine would be
given (e.g., “Today you’re gonna do Hep A and flu”), even if a ‘tag question’ was added to
the end (e.g., “And we’ll do the flu vaccine. Is that okay?”), were coded as presumptive
(Appendix B). Participatory formats allow parents more decision-making latitude. They
included polar interrogatives (e.g., “Are we gonna do the flu vaccine today?”), open
interrogatives (e.g., “How do you feel about the influenza vaccine?”), and a format
presupposing parents would not vaccinate (e.g., “You could come back for flu”). A
secondary independent variable was clinician pursuit of their original recommendation when
parents voiced initial resistance.8,9 We considered clinicians to have pursued if they
continued to advocate their original recommendation immediately after parents verbalized
resistance. We considered clinicians not to have pursued if they accepted parental resistance
or pursued mitigated versions of their original recommendations (Appendix B). For visits
where both influenza and other childhood vaccines were recommended, we coded for
whether the influenza vaccine recommendation: (1) was produced concurrently with other
recommendations (i.e., same stretch/turn of talk) or separately (i.e., as its own independent
recommendation, separated from others by parent talk or other clinician behaviors); and (2)
occurred before or after other recommendations (Appendix B). Additional variables
included demographic and visit characteristics and vaccine hesitancy status. Although the
influenza vaccine dose needed by the child (i.e., first vs. second dose in a season) could
affect clinician communication and parental acceptance, only 3 visits involved a discussion
of a needed second dose and exclusion of these visits did not affect our findings. Thus, all
visits were included in analyses.
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Quantitative Analysis—Demographic and visit characteristics, total PACV score, total
parental visit experience score, and coded clinician-parent communication behaviors were
summarized using descriptive statistics. Pearson’s chi-square and Fisher’s exact tests were
used to assess the relationships between clinician initiation format and clinician pursuit with
parental acceptance of influenza vaccine for their child by the visit’s end and parental visit
experience. Generalized linear mixed models were used to examine the impact of clinician
initiation format on vaccine acceptance and visit experience, adjusting for factors associated
with these outcomes in bivariate analysis (p<0.20) and accounting for clinician clustering.
The effect of clinician pursuit was not assessed using a generalized linear mixed model due
to small sample size. For visits where both influenza and other childhood vaccines were
recommended, the effect of relation (i.e., concurrent vs. separate) and order (i.e., first vs.
last) on the primary outcomes was examined in bivariate analysis. Additionally, coding of
clinician initiation and pursuit formats for influenza vaccine was merged with previous
coding of clinician initiation and pursuit formats for other childhood vaccines.8,9
McNemar’s test was used to compare clinician initiation and pursuit formats for
recommending influenza vs. other childhood vaccines. Given the small sample size, risk
differences (RD) and 95% CIs were calculated for non-significant comparisons. Analyses
were performed using SAS Version 9.4 (Cary, NC).
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RESULTS
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Fifty videotaped health supervision visits involving 17 pediatric clinicians (9 female, 8 male)
from 8 primary care practices (2 university-based, 2 multispecialty group, 2 suburban
private, 1 community hospital-based, 1 urban private) were included (Figure 1). Parents were
primarily mothers who were married, white, ≥30 years of age, had a household income >
$75,000, and were vaccine hesitant (Table 1). Most (85%) had discussed vaccines previously
with their child’s clinician.
There was a slightly higher proportion of visits where clinicians used a presumptive format
(52%) rather than participatory format (48%) to initiate the influenza vaccine
recommendation (Figure 2a). Clinician use of a presumptive initiation format during visits
with non-VHPs and VHPs did not differ significantly (67% vs. 46%, p=0.31; RD 20%, 95%
CI: −13–54%). Over half (56%) of clinicians used the same initiation format for all
recommendations (Appendix C). Among clinicians who used both initiation formats across
visits, the initiation format utilized did not vary by parental vaccine hesitancy status (data
not shown).
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Less than half (44%) of parents immediately accepted the clinician’s initial influenza
vaccine recommendation. Immediate acceptance was higher when the clinician used a
presumptive rather than a participatory format (72% vs. 17%, p<0.01), even among VHPs
(73% vs. 13%, p<0.01). Immediate acceptance did not differ significantly between nonVHPs and VHPs (60% vs. 38%, p=0.29; RD 22%, 95% CI: −15–58%). Among parents who
immediately voiced resistance to the clinician’s initial recommendation, 70% explicitly
rejected the recommendation (93% of whom were VHPs), 25% raised questions or concerns,
and 5% cited contingency plans.
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In response to parental verbal resistance, only 25% of clinicians pursued their original
recommendation (Figure 2b). Fewer clinicians pursued VHPs than non-VHPs (13% vs.
75%; p<0.05) and parents who resisted using an explicit rather than less explicit rejection
(7% vs. 67%; p<0.05). In response to clinician pursuit, 60% of parents voiced immediate
acceptance.
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Overall, 48% of parents accepted influenza vaccine for their child by the visit’s end. A
higher proportion did so if the clinician used a presumptive vs. participatory initiation format
(94% vs. 28%, p<0.001) and if the clinician pursued vs. did not pursue the original
recommendation after the parent initially resisted (80% vs. 13%, p<0.05). The proportion of
parents who accepted influenza vaccine also varied by vaccine hesitancy status (VHPs 39%
vs. non-VHPs 75%, p<0.05), but not by demographic characteristics. In the generalized
linear mixed model, a presumptive initiation format was positively associated with influenza
vaccination acceptance after adjusting for vaccine hesitancy status and accounting for
clinician clustering (AOR 48.2, 95% CI: 3.5–670.5).
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There were 33 visits where the clinician initiated recommendations for both influenza and
other childhood vaccines. Fewer clinicians used a presumptive initiation format for the
influenza vaccine recommendation than for other vaccine recommendations (58% vs. 73%,
p=0.17; RD 15%, 95% CI: −6–36%). Discordant initiation formats were used in 39% of
recommendations. The majority (69%) used a participatory format for influenza and a
presumptive format for other vaccines (Table 2; Appendix D). Parental response to the initial
recommendation was similar for influenza and other vaccines (47% immediate acceptance
for both). In visits where the parent immediately resisted the recommendation for both
(n=13), clinician pursuit differed by vaccine type (p<0.05): 23% of clinicians pursued their
initial recommendation for both, 31% pursued for other vaccines only, and 46% did not
pursue for either. None pursued only their influenza vaccine recommendation.
In 82% of visits where the clinician initiated recommendations for both influenza and other
childhood vaccines (n=27), influenza was mentioned after (rather than before) other
vaccines. In 61% (n=20), the influenza vaccine recommendation was made concurrently
with (rather than separate from) other vaccine recommendations. A higher proportion of
parents accepted influenza vaccine for their child by the visit’s end if the clinician
recommended it concurrently with rather than separately from other vaccines (83% vs. 33%,
p<0.01). The order of the influenza recommendation relative to that for other vaccines did
not have an effect (influenza first 75% vs. influenza last 62%, p=1.0)
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In 56% of visits, parents reported a highly rated visit experience. The proportion of highly
rated visit experiences did not differ between presumptive vs. participatory initiation formats
(52% vs. 63%, p=0.49; RD 11%, 95% CI: −20–42%), pursuit vs. no pursuit (60% vs. 60%;
p=1.0), or VHPs vs. non-VHPs (61% vs. 42%, p=0.25; RD −19%, 95% CI: −52–14%). The
proportion did vary by child gender (75% females vs. 43% males, p<0.05), parent age (86%
18–29 year-olds vs. 45% ≥30 year-olds, p<0.05), and household income (77% ≤$75,000 vs.
39% >$75,000, p<0.01). No association between clinician initiation format and highly rated
visit experience was found in the generalized linear mixed model, after adjusting for these
demographic characteristics and accounting for clinician clustering. In visits where influenza
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and other childhood vaccines were needed, highly rated visit experience did not differ by
recommendation relation or order.

DISCUSSION
To our knowledge, this study is the first to characterize actual clinician-parent
communication behaviors pertaining to influenza vaccination in the primary care setting. We
found that clinician approach to initiating and pursuing the influenza vaccine
recommendation and the contextual relationship of this recommendation with that of other
needed vaccines affected parental acceptance of influenza vaccine for their child without
negatively influencing visit experience. These findings may be particularly valuable when
designing future interventions aiming to increase influenza vaccine uptake among children.
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The association of increased parental acceptance of influenza vaccine for their child with a
presumptive rather than participatory initiation format is consistent with results from our
previous work involving other childhood vaccines8,9 and a recent trial involving the human
papillomavirus (HPV) vaccine.20 It is also in accordance with general evidence illustrating
that subtle wording changes can alter response outcomes.21 The positive association between
clinician pursuit of parents who voiced initial resistance and parental acceptance of influenza
vaccine is also consistent with our data involving other childhood vaccines.8,9 Additionally,
it is in line with evidence suggesting that information and assurances from a clinician are the
main reason why parents planning to delay or decline a vaccine for their child change their
mind.22
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In this study, provider format for initiating the influenza vaccine recommendation and
provider pursuit of this recommendation did not significantly affect parental visit experience.
While our previous analyses assessing the association between clinician communication
behaviors and parental visit experience in the context of other childhood vaccines similarly
found no effect of provider pursuit on parental visit experience, it did show that the
proportion of highly rated visit experiences differed by initiation format (64% presumptive
vs. 96% participatory).9 It is likely that the present study was underpowered to detect a
significant difference in parental visit experience by initiation format. Alternatively, the
discrepancy between studies could reflect inadequate understanding of what constitutes—
and how to measure—parental experience with a vaccine visit, although analyses using only
vaccine-related experience items in the present study still did not show an effect.

Author Manuscript

In visits where both influenza and other childhood vaccines were needed, greater parental
acceptance of influenza vaccine was observed when clinicians combined their
recommendation for influenza with their recommendations for other vaccines, effectively
delivering a single recommendation package. This strategy of avoiding independent
recommendations is similar to that suggested for HPV and other adolescent vaccines.23,24
Further, we found a higher proportion of visits where clinicians used a participatory
initiation format and did not pursue resistant parents for influenza compared to other
vaccines. A similar discrepancy in clinician initiation format was demonstrated recently with
HPV compared to other adolescent vaccines.25 This may reflect a need for increased
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clinician education about the importance of these two vaccines and enhanced vaccine
communication skills training.
This study has several limitations. First, our sample size was small and drawn from one
geographical region. Our results, therefore, may not be generalizable to other clinicians,
practices, or settings. Our sample size also reduced our study power and ability to perform
certain subgroup analyses. Second, parental and clinician attitudes and practices related to
influenza vaccination could have changed between the 2 non-consecutive study periods and
also since our final study period. Additionally, given the observational design, we cannot
account for unobserved confounding. Clinicians who varied their initiation format, for
example, may have opted to do so based upon perceptions of parental vaccine hesitancy,
prior vaccine discussions with parents, or other unmeasured variables.
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CONCLUSION
We found that more parents accepted influenza vaccine for their child when clinicians used a
presumptive format for initiating the influenza vaccine recommendation, pursued their
original recommendation if parents voiced initial resistance, and combined their influenza
vaccine recommendation with that for other childhood vaccines. These communication
behaviors did not appear to negatively impact parental visit experience. Strategies to educate
clinicians about these effective communication practices are needed.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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HIGHLIGHTS
•

Presumptive initiation of influenza vaccine recommendations increases
acceptance

•

Provider pursuit when parents voice initial resistance increases acceptance

•

Bundling vaccine recommendations increases acceptance of influenza vaccine

•

Presumptive initiation, pursuit or recommendation bundling do not affect visit
experience
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FIGURE 1.

Study Sample
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FIGURE 2.

Clinician-Parent Conversation about Influenza Vaccination
a. Clinician Initiation and Parental Response
b. Clinician Pursuit of Parental Resistance
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TABLE 1
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Characteristics of Study Sample (n=50)
Characteristics
Child Sex, % (n)
Male

60 (30)

Female

40 (20)

Child Age (months), mean (SD)

10.4 (3.7)

Participant Relation to Child, % (n)a
Mother

84 (38)

Father

16 (7)

First Born Child, % (n)a

67 (30)

Number of Children in Household, % (n)a

Author Manuscript

1

64 (29)

2

25 (11)

3

7 (3)

4 or more

4 (2)

Parent Age, % (n)a
30 years or older

69 (31)

18–29 years

31 (14)

Parent Highest Education, % (n)a

Author Manuscript

More than 4-year college degree

18 (8)

4-year college degree

35 (16)

Some college or 2-year degree

29 (13)

High school graduate or GED

18 (8)

Household Income, % (n)a
$75,001 or greater

51 (23)

$50,001–$75,000

25 (11)

$30,001–$50,000

11 (5)

$30,000 or less

13 (6)

Marital Status, % (n)a
Married

87 (39)

Single

7 (3)

Living with Partner

7 (3)

Author Manuscript

Parent Hispanic Ethnicity, % (n)a

2 (1)

Parent Race, % (n)a
White

77 (35)

Asian

9 (4)

Black

7 (3)
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Characteristics
Multiracial

7 (3)

Author Manuscript

Parent PACV Score, % (n)
0–49 (Non-Hesitant)

24 (12)

50 or greater (Hesitant)

76 (38)

Prior Parent-Clinician Vaccine Discussion, % (n)a

a

85 (29)

Missing data.
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TABLE 2
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Clinician Initiation Format for Influenza vs. Other Childhood Vaccine Recommendationsa
Influenza Vaccine
Initiation Format

Presumptive, n

Participatory, n

Total, n (%)

Presumptive, n

15

9

24 (73)

Participatory, n

4

5

9 (27)

Total, n (%)

19 (58)

14 (42)

33 (100)

Other Childhood Vaccines

a

Includes 33 visits during which the clinician initiated recommendations for both influenza and other childhood vaccines.
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